We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ZETA:NYSEZeta Global Holdings Corp. Analysis

Data as of 2026-05-28 - not real-time

$19.37

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Zeta Global (ZETA) is trading well below its discounted cash‑flow fair value, offering roughly a mid‑40% upside potential. The 20‑day SMA sits just above the 50‑day SMA, while the 200‑day SMA remains higher, suggesting a modest short‑term bias but a neutral longer‑term trend. Momentum indicators are mixed: the MACD line is above its signal line, generating a bullish signal, yet the RSI hovers in the upper‑mid range, hinting at limited further upside without a catalyst. Volume has been decreasing, which could constrain short‑term price moves, but the stock remains comfortably above its recent support level and well under the identified resistance zone.
Fundamentally, revenue is growing at an impressive rate of nearly 50% year‑over‑year, and operating cash flow is positive despite a thin operating margin. The company’s forward P/E aligns with a fair‑value assessment, while the lack of dividend payout underscores its growth‑oriented profile. Recent strategic collaborations with OpenAI and participation in the Open Semantic Interchange initiative provide credible growth catalysts, reinforcing the strong‑buy analyst consensus.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish MACD crossover with price near support
  • Strong analyst sentiment (strong_buy)
  • Decreasing volume adds caution but does not outweigh upside

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Robust revenue growth and improving cash generation
  • Undervalued relative to DCF fair value
  • Strategic AI partnership expanding addressable market

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Long‑term upside of over 40% versus current price
  • High beta and volatility imply price swings but also reward potential
  • Continued investment in AI‑driven marketing platform drives sustainable growth

Key Metrics & Analysis

Financial Health

Revenue Growth49.90%
Profit Margin-1.61%
P/E Ratio16.3
ROE-2.97%
ROA1.55%
Debt/Equity24.83
P/B Ratio5.9
Op. Cash Flow$213.8M
Free Cash Flow$254.8M
Industry P/E40.4

Technical Analysis

TrendNeutral
RSI61.2
Support$15.60
Resistance$20.54
MA 20$17.94
MA 50$17.15
MA 200$18.54
MACDBullish
VolumeDecreasing
Fear & Greed Index92.16

Valuation

Fair Value$37.04
Target Price$28.31
Upside/Downside46.14%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta2.77
Volatility53.88%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.